CDKN1A and cancer: Histone deacetylase inhibitors can increase p21 expression and, when used in combination with cytotoxic agents, can induce cell death or cell cycle arrest in cancer cells such as hepatocellular carcinoma, ovarian cancer, and prostate cancer [255,256].